Structure and solution behaviour of cyclooctadiene complexes of platinum(II)

The substitution behaviour of [PtCl(R)(COD)] (R⁻ = Me and Fc) complexes, by the stepwise addition of phosphine ligands, L (L = PPh₃, PEt₃ and P(NMe₂)₃), were investigated in situ by ¹H and ³¹P NMR spectroscopy. Addition of less than two equivalents of the phosphine ligand results in the formation of dimeric molecules with the general formula trans-[Pt(R)(μ-Cl)(L)]₂ for the sterically demanding systems where R⁻ = Me/L = P(NMe₂)₃ and R⁻ = Fc/L = PEt₃, PPh₃ and P(NMe₂)₃ while larger quantities resulted in cis- and trans mixtures of mononuclear complexes being formed. In the case of the relatively small steric demanding, strongly coordinating, PEt₃ ligand the trans-[PtCl(R)(PEt₃)₂] mononuclear complexes were exclusively observed in both cases. The crystal structures of the two substrates, [PtCl(R)(COD)] (R⁻ = Me or Fc), as well as the cis-[PtCl(Fc)(PPh₃)₂] substitution product are reported.     

Synthesis, characterization, and aqueous chemistry of cytotoxic Au(III) polypyridyl complexes

This work reports the synthesis, characterization, and aqueous chemistry of a series of cytotoxic [Au(polypyridyl)Cl₂]PF₆ complexes {(where polypyridyl = dipyrido[3,2-f:2′,3′-h] quinoxaline (DPQ), dipyrido[3,2-a:2′,3′-c] phenazine (DPPZ) and dipyrido[3,2-a:2′,3′-c](6,7,8,9-tetrahydro) phenazine (DPQC))}. The crystal structure of [Au(DPQ)Cl₂]PF₆ was determined as example of the series and exhibits the anticipated square planar geometry common for d⁸ coordination complexes. The crystals of the complex belong to the space group P2₁/n with a = 7.624(2) Å, b = 18.274(5) Å, c = 14.411(14) Å, β = 98.03(3)°, and Z = 4. In ¹H NMR studies of these compounds in the presence of aqueous buffer, all four complexes rapidly converted to the dihydroxy species [Au(polypyridyl)(OH)₂] in a stepwise fashion. However, the [Au(polypyridyl)]³⁺ fragment believed to impart cytotoxicity in human ovarian cancer cell lines (A2780) remained intact and appeared stable for days. It was also noted that these Au(III) complexes were readily reduced in the presence of the common biological reducing agents, reduced glutathione and sodium ascorbate. How solution and redox stability may affect the biological activity of these novel Au(III) complexes is discussed.     

Synthesis and characterization of gold(III) complexes with alkyldiamine ligands

A series of gold(III) metalacycle of five-, six- and seven-membered ring was prepared by reacting Auric acid (HAuCl₄ · 3H₂O) with 1 equiv. unsubstituted ethylenediamine (en), propylene diamine (pn) and butylenediamine (bn) ligands and with some N-mono-substituted as well as N,N′-disubstituted ethylenediamine ligands. The general formula of these complexes is [Au(alkyldiamine)Cl₂]Cl. These complexes are characterized by melting point and elemental analysis, while structural analysis was done by spectroscopic techniques such as UV-Vis, Far-IR, IR spectroscopy, ¹H and ¹³C solution as well as ¹³C and ¹⁵ N solid-state NMR. The solid-state ¹⁵ N NMR shows that the chemical shift difference between free and bound ligand decreases as bn > pn > en, indicating stronger Au-N bond for bn complex compared to pn and en. UV-Vis shows relative stability of the Au(III) complexes of unsubstituted ethylenediamine with respect to N,N′-di-substituted ethylenediamine. Far-IR data show the six-membered metalacycle gold(III) alkanediamine complexes to be more stable. Spectroscopic data are evaluated by comparisons with calculated data of the built and optimized structure by gaussian03 at the RB3LYP level with LanL2DZ bases set.     

Syntheses and properties of new metal-carbon bonded heteroleptic complexes of ruthenium(II) containing terpyridine coligand

Reactions of 2-(arylazo)aniline, HL [H represents the dissociable protons upon orthometallation and HL is p-RC₆H₄N = NC₆H₄-NH₂; R = H for HL¹; CH₃ for HL² and Cl for HL³] with Ru(R₁-tpy)Cl₃ (where R₁-tpy is 4′-(R₁)-2,2′,6′′,2′′-terpyridine and R₁ = H or 4-N,N-dimethylaminophenyl or 4-methylphenyl) afford a group of complexes of type [Ru(L)(R₁-tpy)]·ClO₄ each of which contains C,N,N coordinated L⁻ as a tridentate ligand along with a terpyridine. Structure of one such complex has been determined by X-ray crystallography. All the Ru(II) complexes are diamagnetic, display characteristic ¹H NMR signals and intense dπ(Ru^II) → π∗(tpy) MLCT transitions in the visible region. Cyclic voltammetric studies on [Ru(L)(R₁-tpy)]·ClO₄ complexes show Ru(II)-Ru(III) oxidation within 0.63-0.67 V versus SCE.     

X-ray structure and magnetic properties of dinuclear and polymer iron(II) complexes

Five new octahedral iron(II) complexes [FeL2(4-dpa)]_n(EtOH) (1), [FeL2(bipy)]_n(DMF) (2), [FeL1(bpee)]_n (3), [Fe₂L3(1-meim)₄](1-meim)₄ (4) and [FeL1(DMAP)₂] (5), with L1 and L2 being tetradentate coordinating Schiff base like ligands (L1 = (E,E)-[{diethyl-2,2′-[1,2-phenylenebis(iminomethylidyne)]bis[3-oxobutanato](2-)-N,N′,O³,O³′}, L2 = (3,3′)-[{1,2-phenylenebis(iminomethylidyne)]bis(2,4-pentane-dionato)(2-)-N,N′,O²,O²′}) and L3 being a octadentate dinucleating coordinating Schiff base like ligand ({tetraethyl-(E,E,E,E)-2,2′,2′′,2′′′-[1,2,4,5-phenylentetra(iminomethylidine)]tetra[3-oxobutanoato](2-)-N,N′,N′′,N′′′,O³,O³′,O³′′,O³′′′}); 4-dpa = di(4-picolyl)-amine, bipy = 4,4′-bipyridine, bpee = trans-1,2-bis(4-pyridyl)ethylene, 1-meim = 1-methylimidazole and DMAP = 4-dimethylaminopyridine, have been synthesized and characterised using X-ray structure analysis and T-dependent susceptibility measurements. Both methods indicate that all iron(II) centres are in the paramagnetic high-spin state over the whole temperature range investigated. The O-Fe-O angle, the so called bit of the equatorial ligand, is with an average of 111° in the region typical for high-spin iron(II) complexes of this ligand type. In the case of compound 1 an infinite two-dimensional hydrogen bond network can be found, for the compounds 2-4 no hydrogen bond interactions are observed between the complex molecules. A comparison of the curve progression obtained from the magnetic measurements of the mononuclear complex 5 and the polymeric complexes 1-3 leads to the conclusion that no magnetic interactions are mediated over the bridging axial ligands. For the dinuclear complex 4 weak antiferromagnetic interactions between the two iron centres are found.     

Synthesis and properties of red emitter Ru(II) complexes based on 6,6′-disubstituted-4,4′-bipyrimidine

Heteroleptic complexes [Ru(bpy)₂(R₂bpm)]²⁺, where bpy = 2,2′-bipyridine and R₂bpm = 6,6′-diaryl-4,4′-bipyrimidine, have been synthesized and characterized, together with the homoleptic complex [Ru(R₂bpm)₃]²⁺, in which R₂bpm = 6,6′-diphenyl-4,4′-bipyrimidine. The substituent aryl on the bipyrimidine has significant effects on the properties of these complexes as compared to the parent [Ru(bpy)₂(bpm)]²⁺ complex. The complexes exhibit Ru-to-bpm charge transfer (CT) absorptions centered at about 540 nm and Ru-to-bpy CT absorptions centered at about 435 nm. The assignment of the low energy absorptions is supported by the relative ease of the reduction of the new complexes as compared to [Ru(bpy)₃]²⁺. The new complexes exhibit a relatively intense emission at room temperature, with lifetimes in the 10-50 ns range, with the homoleptic species exhibiting the higher-energy (maximum at 724 nm) and the longest-lived (τ = 48 ns) emission among the complexes. Luminescence lifetimes and quantum yields are governed by the energy gap law, indicating that direct deactivation to the ground state is the dominant relaxation pathway for 1-6, while thermally activated processes are inefficient.     

Structural and solution chemistry, protein binding and antiproliferative profiles of gold(I)/(III) complexes bearing the saccharinato ligand

A series of new gold(I) and gold(III) complexes based on the saccharinate (sac) ligand, namely M[Au(sac)₂] (with M being Na⁺, K⁺ or NH₄⁺), [(PTA)Au(sac)], K[Au(sac)₃Cl] and Na[Au(sac)₄], were synthesized and characterized, and some aspects of their biological profile investigated. Spectrophotometric analysis revealed that these gold compounds, upon dissolution in aqueous media, at physiological pH, manifest a rather favourable balance between stability and reactivity. Their reactions with the model proteins cytochrome c and lysozyme were monitored by mass spectrometry to predict their likely interactions with protein targets. In the case of disaccharinato gold(I) complexes, cytochrome c adducts bearing four coordinated gold(I) ions were preferentially formed in high yield. In contrast, [(PTA)Au(sac)] (PTA = 1,3,5-triaza-7-phosphaadamantane) turned out to be poorly effective, only producing a mono-metalated adduct in very low amount. In turn, the gold(III) saccharinate derivatives were less reactive than their gold(I) analogues: K[Au(sac)₃Cl] and Na[Au(sac)₄] caused moderate protein metalation, again with evidence of formation of tetragold adducts. Finally, the above mentioned gold compounds were challenged against the reference human tumor cell line A2780S and its cisplatin resistant subline A2780R and their respective cytotoxic profiles determined. [(PTA)Au(sac)] turned out to be highly cytotoxic whereas moderate cytotoxicities were observed for the gold(III) complexes and only modest activities for disaccharinato gold(I) complexes. The implications of these results are thoroughly discussed in the light of current knowledge on gold based drugs.     

Synthesis, spectroscopy, structure and photophysical properties of dinaphthylmethylarsine complexes of palladium(II) and platinum(II)

Dinaphthylmethylarsine complexes of palladium(II) and platinum(II) with the formulae [MX₂L₂] (M = Pd, Pt; L = di(1-naphthyl)methylarsine = Nap₂AsMe and X = Cl, Br, I), [M₂Cl₂(μ-Cl)₂L₂], [PdCl(S₂CNEt₂)L], [Pd₂Cl₂(μ-OAc)₂L₂] and [MCl₂(PR₃)L] (PR₃ = PEt₃, PPr₃, PBu₃, PMePh₂) have been prepared. These complexes have been characterized by elemental analyses, IR, Raman, NMR (¹H, ¹³C, ³¹P) and UV-vis spectroscopy. The stereochemistry of the complexes has been deduced from the spectroscopic data. The crystal structures of trans-[PdCl₂(PEt₃)(Nap₂AsMe)] and of [Pd(S₂CNEt₂)₂], a follow-up product, were determined. The UV-vis spectra of [MX₂L₂] complexes show a red shift on going from X = Cl to X = I. The complexes [PdX₂L₂] and [PtX₂L₂] are strongly luminescent in fluid solution and in the solid at ambient temperature.     

Syntheses, characterization, and DFT investigation of new mononuclear acetonitrile- and chloro-ruthenium(II) terpyridine complexes

A series of mononuclear acetonitrile complexes of the type [Ru(CH₃CN)(L)(terpy)]²⁺ {L = phen (1), dpbpy (3), and bpm (5)}, and their reference complexes [RuCl(L)(terpy)]⁺ {L = phen (2), dpbpy (4), and dpphen (6)} were prepared and characterized by electrospray ionization mass spectrometry, UV-vis spectroscopy, and cyclic voltammograms (CV). Abbreviations of the ligands (Ls) are phen = 1,10-phenanthroline, dpbpy = 4,4′-diphenyl-2,2′-bipyridine, bpm = 2,2′-bipyrimidine, dpphen = 4,7-diphenyl-1,10-phenanthroline, bpy = 2,2′-bipyridine, and terpy = 2,2′:6′,2″-terpyridine. The X-ray structures of the two complexes 2 and 3 were newly obtained. The metal-to-ligand charge transfer (MLCT) bands in the visible region for 1, 3, and 5 in acetonitrile were blue shifted relative to those of the reference complexes [RuCl(L)(terpy)]⁺. CV for all the [Ru(CH₃CN)(L)(terpy)]²⁺ complexes showed the first oxidation wave at around 0.95 V, being more positive than those of [RuCl(L)(terpy)]⁺. The time-dependent-density-functional-theory approach (TDDFT) was used to interpret the absorption spectra of 1 and 2. Good agreement between computed and experimental absorption spectra was obtained. The DFT approach also revealed the orbital interactions between Ru(phen)(terpy) and CH₃CN or Cl⁻. It is demonstrated that the HOMO-LUMO energy gap of the acetonitrile ligand is larger than that of the Cl⁻ one.     

DNA-binding and photocleavage studies of mixed polypyridyl ruthenium(II) complexes with calf thymus DNA

New mixed polypyridyl {NMIP = 2′-(2″-nitro-3″,4″-methylenedioxyphenyl)imidazo-[4′,5′-f][1,10]-phenanthroline, dmb = 4,4′-dimethyl-2,2′-bipyridine, bpy = 2,2′-bipyridine} ruthenium(II) complexes [Ru(dmb)₂(NMIP)]²⁺ (1) and [Ru(bpy)₂(NMIP)]²⁺ (2) have been synthesized and characterized. The binding of these complexes to calf thymus DNA (CT-DNA) has been investigated with spectroscopic methods, viscosity and electrophoresis measurements. The experimental results indicate that both complexes could bind to DNA via partial intercalation from the minor/major groove. In addition, both complexes have been found to promote the single-stranded cleavage of plasmid pBR 322 DNA upon irradiation. Under comparable experimental conditions compared with [Ru(phen)₂(NMIP)]²⁺, during the course of the dialysis at intervals of time, the CD signals of both complexes started from none, increased to the maximum magnitude, then no longer changed, and the activity of effective DNA cleavage dependence upon concentration degree lies in the following order: [Ru(phen)₂NMIP]²⁺ > complex 2 > complex 1.     

Experimental and DFT studies on the DNA-binding trend and spectral properties of complexes [Ru(bpy)2L] (L = dmdpq, dpq, and dcdpq)

The trend in DNA-binding affinities and the spectral properties of a series of Ru(II) polypyridyl complexes, [Ru(bpy)₂(dmdpq)]²⁺ (1), [Ru(bpy)₂(dpq)]²⁺ (2), [Ru(bpy)₂(cndpq)]²⁺ (3) (bpy = 2,2′-bipyridine; dpq = dipyrido[3,2-d:2′,3′-f]quinoxaline; dmdpq = di-methyl-dpq; dcdpq = di-cyano-dpq), have been experimentally and theoretically investigated. The DNA-binding constants K_b of the complexes were determined systematically with spectrophotometric titration. The density functional theory (DFT) and time-dependent DFT (TDDFT) calculations were carried out for these complexes. The experimental results show that these complexes bind to DNA in intercalation mode, and the order of their intrinsic DNA-binding constants K_b is K_b(1) < K_b(2) ? K_b(3). The substituents on the intercalative ligands of the complexes play a very important role in the control of DNA-binding affinities of the complexes, in particular, the stronger electron-withdrawing substituent (-CN) on the intercalative ligand can greatly improve the DNA-binding property of the derivative complex. The trend in DNA-binding affinities as well as the spectral properties of metal-ligand charge-transition (¹MLCT) of this series of complexes can be reasonably explained by applying the DFT and TDDFT calculations and the frontier molecular orbital theory.     

Interaction of Pt(II) and Pd(II) complexes of terpyridine with 1-methylazoles: A combined experimental and density functional study

The synthesis and characterization of several complexes of the composition [{M(terpy)}_n(L)](ClO₄)_m (M = Pt, Pd; L = 1-methylimidazole, 1-methyltetrazole, 1-methyltetrazolate; terpy = 2,2′:6′,2″-terpyridine; n = 1, 2; m = 1, 2, 3) is reported and their applicability in terms of a metal-mediated base pair investigated. Reaction of [M(terpy)(H₂O)]²⁺ with 1-methylimidazole leads to [M(terpy)(1-methylimidazole)](ClO₄)₂ (1: M = Pt; 2: M = Pd). The analogous reaction of [Pt(terpy)(H₂O)]²⁺ with 1-methyltetrazole leads to the organometallic compound [Pt(terpy)(1-methyltetrazolate)]ClO₄ (3) in which the aromatic tetrazole proton has been substituted by the platinum moiety. For both platinum(II) and palladium(II), doubly metalated complexes [{M(terpy)}₂(1-methyltetrazolate)](ClO₄)₃ (4: M = Pt; 5: M = Pd) can also be obtained depending on the reaction conditions. In the latter two compounds, the [M(terpy)]²⁺ moieties are coordinated via C5 and N4. X-ray crystal structures of 1, 2, and 3 are reported. In addition, DFT calculations have been carried out to determine the energy difference between fully planar [Pd(mterpy)(L)]²⁺ complexes Ip-IVp (mterpy = 4′-methyl-2,2′:6′,2″-terpyridine; L = 1-methylimidazole-N3 (I), 1-methyl-1,2,4-triazole-N4 (II), 1-methyltetrazole-N3 (III), or 3-methylpyridine-N1 (IV)) and the respective geometry-optimized structures Io-IVo. Whereas this energy difference is larger than 70 kJ mol⁻¹ for compounds I, II, and IV, it amounts to only 0.8 kJ mol⁻¹ for the tetrazole-containing complex III, which is stabilized by two intramolecular C-H?N hydrogen bonds. Of all complexes under investigation, only the terpyridine-metal ion-tetrazole system with N3-coordinated tetrazole appears to be suited for an application in terms of a metal-mediated base pair in a metal-modified oligonucleotide.     

Synthesis, crystal structure and spectroscopic behaviors of Co(II) and Cu(II) complexes with Salen-type bisoxime ligands

Two Salen-type ligands (H₂L¹, 4,4′-dichloro-2,2′-[(1,3-propylene)dioxybis(nitrilomethylidyne)]diphenol and H₂L², 4,4′-dinitro-2,2′-[ethylenedioxybis(nitrilomethylidyne)]diphenol) and their corresponding complexes ({[CoL¹(MeOH)]₂(OAc)₂Co} · 2MeOH and [CuL²]₂) have been synthesized and characterized by element analyses, ¹H NMR, FT-IR and UV-Vis spectra, TG-DTA and single crystal X-ray crystallography. Crystallographic data suggests the octahedral geometry for Co(II) complex and square-pyramidal geometry for Cu(II) complex. Furthermore, the fluorescence behavior of Cu(II) complex in DMSO is discussed.     

Reactions of cyanooxo-molybdates and -tungstates with picolinic acid, 2-pyridinecarboxaldehyde and 2,2′-pyridil: X-ray crystal structure of (PPh4)2[Mo(CN)4O(pic)] · 2.5H2O

The syntheses of (PPh₄)₂[M(CN)₃O(pic)] · nH₂O (M = Mo, W; n = 2.5, 4; pic = picolinate anion) as well as (PPh₄)₂[Mo(CN)₄O(apic)] · 3H₂O (apic = 2-pyridinecarboxaldehyde) are presented. The salts have been characterised by elemental analysis, IR and UV-Vis spectroscopy, cyclic voltammetry and X-ray crystal structure determination of (PPh₄)₂[Mo(CN)₃O(pic)] · 2.5H₂O. The anion in the latter salt is approximately octahedral with O and N donor atoms of pic situated in the trans and cis position to the MoO bond, respectively. The picolinate complexes have the characteristic MLCT bands in the visible spectra with the absorption maxima linearly dependent on the Reichardt’s E_T solvent parameter. These complexes are shown to exhibit the strongest solvatochromic effect of all studied tricyanooxo and hexacyano complexes of Mo(IV) and W(IV). The obtained values of E_1/2 in these salts [0.333 V (Mo) and 0.018 V (W) in 1,2-C₂H₄Cl₂] were found to be the highest of all [M(CN)₃O(LL)]²⁻ type complexes making these salts show reversibility in a remarkable variety of solvents. The oxidation of coordinated apic to pic has been demonstrated by means of electronic spectroscopy. The isolated salts were used to monitor the reaction of [M(CN)₄O(H₂O)]²⁻ with 2,2′-pyridil in water-ethanol solution. It was found that 2,2′-pyridil disproportionate to Hpic and apic in the first step and the other decomposition products of 2,2′-pyridil postulated in the literature were not observed.     

Enhanced DNA photocleavage properties of Ru(II) terpyridine complexes upon incorporation of methylphenyl substituted terpyridine and/or the polyazine bridging ligand dpp (2,3-bis(2-pyridyl)pyrazine)

The heteroleptic complexes, [(MePhtpy)RuCl(dpp)](PF₆) and [(tpy)RuCl(dpp)](PF₆), have been synthesized, characterized, and investigated with respect to their photophysical, redox, and DNA photocleavage properties (where MePhtpy = 4′-(4-methylphenyl)-2,2′:6′,2′′-terpyridine and dpp = 2,3-bis(2-pyridyl)pyrazine, tpy = 2,2′:6′,2′′-terpyridine). The X-ray crystal structure confirms the identity of the new [(MePhtpy)RuCl(dpp)](PF₆) complex. These heteroleptic complexes were found to photocleave DNA in the presence of oxygen, unlike the previously studied complex, [Ru(tpy)₂](PF₆)₂. The photophysical, redox, and DNA photocleavage properties of the heteroleptic complexes were compared with those of the homoleptic complexes, [Ru(MePhtpy)₂](PF₆)₂ and [Ru(tpy)₂](PF₆)₂. The heteroleptic complexes showed intense metal to ligand charge transfer (MLCT) transition at lower energy ([(MePhtpy)RuCl(dpp)](PF₆), 522 nm; [(tpy)RuCl(dpp)](PF₆), 516 nm) and longer excited state lifetimes as compared to the homoleptic complexes. The [Ru(MePhtpy)₂]²⁺ complex was found to photocleave DNA in contrast to [Ru(tpy)₂]²⁺. The introduction of a methylphenyl group on the tepyridine ligand not only enhances the ³MLCT excited state lifetime but also increases the lipophilicity and thereby the DNA binding ability of the molecule. An increase in lipophilicity upon addition of a methylphenyl group on the 2,2′:6′,2′′-terpyridine ligand was confirmed by determination of the partition coefficient ([(MePhtpy)RuCl(dpp)](PF₆), log P = +1.16; [(tpy)RuCl(dpp)](PF₆), log P = −1.27). The heteroleptic complexes photocleave DNA more efficiently than the homoleptic complexes, with the greatest activity being observed for the newly prepared [(MePhtpy)RuCl(dpp)](PF₆) complex.     

Synthesis and characterization of Os(II)(dpop′) (dpop′ = dipyrido(2,3-a;3′,2′-j)phenazine) complexes with 2,2′-bipyridine(bpy); 2,2′-bipyrimidine(bpm) and 2,3-bis(2-pyridyl)pyrazine(dpp)

New Os(II) complexes including [Os(dpop′)₂](PF₆)₂ (dpop′= dipyrido(2,3-a;3′,2′-j)phenazine) and a series of mixed ligand [Os(dpop′)(N-N)Cl]PF₆ (N-N = 2,2′-bipyridine(bpy); 2,2′-bipyrimidine(bpm) and 2,3-bis(2-pyridyl)pyrazine(dpp)) were synthesized. The Os dπ → dpop′ π^∗ MLCT transitions for [Os(dpop′)₂]²⁺ are observed at lower energy than for Os dπ → tpy π^∗ (tpy = 2,2′:6′,2″-terpyridine) and Os dπ → tppz π^∗ (tppz = 2,3,5,6-tetrakis(2-pyridyl)pyrazine) (The ligand abbreviations tpd, tpp and tpypz have also appeared in the literature for 2,3,5,6- tetrakis(2-pyridyl)pyrazine in addition to tppz.) MLCT transitions in the comparative [Os(tpy)₂]²⁺ and [Os(tppz)₂]²⁺ complexes. The Os dπ → dpop′ π^∗ MLCT transitions are observed at lower energy in mixed bidentate ligand N-N systems compared with [Os(dpop′)₂]²⁺. Cyclic voltammetry shows more positive osmium oxidation, and less negative ligand reduction potentials for [Os(dpop′)₂]²⁺ as compared to [Os(tpy)₂]²⁺ and [Os(tppz)₂]²⁺ complexes. The osmium oxidation potentials in mixed ligand [Os(dpop′)(N-N)Cl]⁺ complexes are at less positive potential than for the [Os(dpop′)₂]²⁺ ion. NMR results show different chemical shifts for ring protons either trans or cis to dpop′ in mixed ligand systems, and also show two geometrical isomers for the [Os(dpop′)(dpp)Cl]⁺ complex. The [Os(dpop′)(dpp)Cl]⁺ geometric isomer with the pyrazine ring of dpp trans to dpop′ is found more predominate by 1.0/0.7 over the isomer with the pyrazine ring of dpp cis to dpop′ and that inter-conversion of geometric isomers does not occur in room temperature solution on the NMR timescale.     

Synthesis of novel mononuclear and dinuclear ruthenium(II) complexes with terpyridine and acetylacetonate ancillary ligands and cyanamide derivative ligands

Several new mononuclear and dinuclear ruthenium(II) complexes - incorporating 2,2′:6′,2″-terpyridine and acetylacetonate as ancillary ligands and phenylcyanamide derivative ligands - of the type [Ru(tpy)(acac)(L)] and [{Ru(tpy)(acac)}₂(μ-L′)] (where tpy = 2,2′:6′,2″-terpyridine, acac = acetylacetonate, L = hmbpcyd = 4-(3-hydroxy-3-methylbutynyl)phenylcyanamide anion (2) and epcyd = 4-ethynylphenylcyanamide anion (3) and L′ = bcpda = bis(4-cyanamidophenyl)diacetylene dianion (4) and bcpea = 9,10-bis(4-cyanamidophenylethynyl)anthracene dianion (5)) were synthesized in a stepwise manner starting from [Ru(tpy)(acac)(Ipcyd)] (1), where Ipcyd = 4-iodophenylcyanamide anion. Tetraphenylarsonium salts of the phenylcyanamide derivative ligands were also prepared. The four complexes have been characterized by UV-Vis, IR, ES-MS, electrochemistry and ¹H NMR. Mononuclear complexes 2 and 3 were further characterized by ¹³C NMR. The single crystal X-ray structure of 2 was determined, it crystallized with one molecule of water with empirical formula of C₃₂H₃₁N₅O₅Ru, in a monoclinic crystal system and space group of P2₁/n with a = 17.642(5) Å, b = 9.634(2) Å, c = 20.063(7) Å, β = 92.65(3)°, V = 3406(2) Å³ and Z = 4. The structure was refined to a final R factor of 0.040. The Ru(III/II) couple of 1-3 appeared around 0.34 V versus the saturated calomel electrode in dimethylformamide and at a slightly higher potential, around 0.36-0.37 V for 4 and 5. Spectroelectrochemical studies were also performed for 4 and 5, no intervalence transition was observed despite all attempts.     

Mercaptoethanesulfonic acid (CoM imitator) interaction studies with nickel(II) complexes of pyridyl groups containing tetradentate ligands: Synthesis, structure, spectra and redox properties

Nickel(II) complexes of N,N′-dimethyl-N,N′-bis(pyridyl-2yl-methyl)ethylene-diamine (L¹), N,N′-dimethyl-N,N′-bis(pyridyl-2-ylmethyl)-1,2-diaminopropane (L²) and N,N′-dimethyl-N,N′-bis(pyridyl-2-ylmethyl)-1,3-diaminopropane (L³) were prepared and their spectroscopic and redox properties studied. The distorted octahedral structure was determined for [NiL³ClCH₃OH](ClO₄) by using X-ray crystallography. The electronic spectral behavior of the complexes at different pHs was analyzed; it is shown that a new band grew at the expense of the other band intensity in acid media. The redox properties of ligands and their complexes show the peaks of Ni(II) → Ni(III) and Ni(II) → Ni(0) as these were detected at low concentration while Ni(II) → Ni(I) process was detectable clearly at high concentration. Furthermore, the interaction studies of 2-mercaptoethanesulfonic acid as a simulator of coenzyme M reductase (CoM) with NiN₄ chromophores are discussed.     

[Ru(phen)2(dppz)] as an efficient optical probe for staining nuclear components

The ‘molecular light switch’ complexes [Ru(bpy)₂(dppz)]²⁺ (1) and [Ru(phen)₂(dppz)]²⁺ (2), where bpy = 2,2′-bipyridine, phen = 1,10-phenanthroline and dppz = dipyrido[3,2-a:2′,3′-c]phenazine, have been explored as probes for diagnosing and staining nuclear components. The phen complex acts as a better staining agent for nonviable cells than for viable cells and exhibits a staining efficiency in tail region of comet more specific and stronger than the already known dye Hoechst 33258.